Decision Historical Financial Ratios
| DECN Stock | USD 0.0001 0.00 0.00% |
Decision Diagnostics is recently reporting on over 79 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 182 or Book Value Per Share of 0.002 will help investors to properly organize and evaluate Decision Diagnostics financial condition quickly.
Decision |
About Decision Financial Ratios Analysis
Decision DiagnosticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Decision Diagnostics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Decision financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Decision Diagnostics history.
Decision Diagnostics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Decision Diagnostics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Decision Diagnostics sales, a figure that is much harder to manipulate than other Decision Diagnostics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Payout Ratio
Payout Ratio is the proportion of Decision Diagnostics earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of Decision Diagnostics dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating Decision Diagnostics is paying out more in dividends than it makes in net income.Most ratios from Decision Diagnostics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Decision Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.At this time, Decision Diagnostics' Debt To Equity is very stable compared to the past year.
| 2019 | 2020 | 2023 | 2024 (projected) | PTB Ratio | 24.89 | 9.92 | 8.93 | 9.38 | Price To Sales Ratio | 0.92 | 2.42 | 2.79 | 2.65 |
Decision Diagnostics fundamentals Correlations
Click cells to compare fundamentals
Decision Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Decision Diagnostics fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 3.46 | 1.12 | 0.92 | 2.42 | 2.79 | 2.65 | |
| Ptb Ratio | 3.78 | 2.13 | 24.89 | 9.92 | 8.93 | 9.38 | |
| Days Sales Outstanding | 85.0 | 155.04 | 160.34 | 174.05 | 200.16 | 181.67 | |
| Book Value Per Share | 0.0183 | 0.009395 | 5.82E-4 | 0.001814 | 0.002086 | 0.001982 | |
| Operating Cash Flow Per Share | (0.0165) | (0.0106) | (0.007413) | (0.005271) | (0.004744) | (0.004981) | |
| Pb Ratio | 3.78 | 2.13 | 24.89 | 9.92 | 8.93 | 9.38 | |
| Ev To Sales | 3.96 | 1.64 | 2.04 | 3.58 | 4.12 | 3.92 | |
| Free Cash Flow Per Share | (0.0178) | (0.0113) | (0.008187) | (0.005271) | (0.004744) | (0.004981) | |
| Roic | (0.63) | (0.69) | (0.4) | (0.62) | (0.56) | (0.59) | |
| Inventory Turnover | 6.16 | 7.69 | 9.18 | 9.22 | 10.6 | 10.07 | |
| Days Of Inventory On Hand | 59.27 | 47.44 | 39.78 | 39.61 | 35.65 | 48.08 | |
| Payables Turnover | 2.42 | 1.87 | 1.22 | 0.87 | 1.0 | 0.95 | |
| Sales General And Administrative To Revenue | 1.19 | 0.94 | 0.73 | 1.17 | 1.05 | 1.36 | |
| Cash Per Share | 0.0116 | 0.00287 | 7.6E-4 | 0.00196 | 0.002253 | 0.002141 | |
| Pocfratio | (4.18) | (1.89) | (1.96) | (3.42) | (3.07) | (2.92) | |
| Days Payables Outstanding | 150.78 | 194.97 | 299.35 | 419.79 | 377.81 | 223.38 | |
| Income Quality | 0.52 | 0.59 | 0.36 | 0.0474 | 0.0426 | 0.0448 | |
| Roe | (1.74) | (1.91) | (35.76) | (61.35) | (70.55) | (67.03) | |
| Ev To Operating Cash Flow | (4.78) | (2.78) | (4.36) | (5.05) | (4.54) | (4.32) | |
| Return On Tangible Assets | (0.83) | (0.88) | (1.11) | (9.38) | (8.44) | (8.02) | |
| Ev To Free Cash Flow | (4.45) | (2.6) | (3.95) | (5.05) | (5.81) | (6.1) | |
| Current Ratio | 0.83 | 0.58 | 0.27 | 0.33 | 0.3 | 0.28 | |
| Tangible Book Value Per Share | 9.99E-4 | (0.00435) | (0.016) | (0.00753) | (0.00866) | (0.008227) | |
| Receivables Turnover | 4.29 | 2.35 | 2.28 | 2.1 | 2.41 | 2.29 | |
| Shareholders Equity Per Share | 0.0183 | 0.009395 | 5.82E-4 | 0.001814 | 0.002086 | 0.001982 | |
| Debt To Equity | 1.18 | 1.3 | 35.74 | 6.05 | 5.44 | 5.72 |
Pair Trading with Decision Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Decision Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decision Diagnostics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Decision Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Decision Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Decision Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Decision Diagnostics to buy it.
The correlation of Decision Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Decision Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Decision Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Decision Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.